Contamac announces FDA Premarket approval (PMA) of Optimum Infinite (tisilfocon A) material for use in orthokeratology overnight wear. Contamac, a global leader in specialty contact lens and intraocular lens materials today announced U.S. Food and Drug Administration (FDA) Premarket approval for the Optimum Infinite (tisilfocon A) Orthokeratology Lenses II. Outside the USA, this approval in…
In February, BostonSight announced a transformative 5-year strategic roadmap aimed at redefining ocular surface treatment through groundbreaking advancements in clinical research, education, and specialty lens technology. The organization has designated key leadership roles to lead initiatives that accelerate innovation and collaboration, with the goal of positively impacting patient lives around the world. Dr. Karen Carrasquillo,…
Alcon reported $683 million in contact lens sales for Q4 2025, a 7 percent year-on-year increase driven by new product launches and price increases, particularly in North America. Price resistance was stronger elsewhere: “If you look at the European market, you have got a lot of big chains who basically are telling us they are…
Art Optical Contact Lens, Inc., a provider of custom contact lenses, in partnership with Contamac, a manufacturer of contact and intraocular lens materials, recently named the winners of their Specialty Contact Lens Travel Grants. According to the announcement, these individuals have demonstrated the use of Art Optical lens designs to solve patient needs in unique…
Menicon Co., Ltd, a global contact lens manufacturer, announced that it has concluded its Rose K manufacturing partnership with Blanchard Contact Lenses, a division of CooperVision, effective December 31, 2025. Blanchard had been an important and valued Rose K partner since 2003, the company said, contributing more than two decades of expertise to the fitting,…
LENZ Therapeutics, Inc., a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%, has announced certain preliminary unaudited financial results for the fourth quarter ended December 31, 2025 and recent corporate updates. Approved by the FDA in August 2025, VIZZ is a once-daily aceclidine-based eye drop for the treatment of age-related presbyopia….
The Contact Lens Institute (CLI) has announced the winners of its 2025 Contact Lens Institute Culture Awards, recognizing five U.S. and Canadian eyecare teams and individuals. These honorees were selected for their successful efforts in cultivating contact lens cultures that lead to improved patient experiences and better business outcomes, the group advised. According to the…
The Eye Consortium (TEC), an alliance group for independent practices, has formed a new Elite Vendor partnership with Bausch + Lomb to help advance TEC’s ongoing commitment to deliver programs and resources that help the alliance’s member doctors elevate both the patient experience and practice profitability. “In response to the overwhelming interest from our membership,…
Prevent Blindness, has announced that Matt MacDonald, president and global head of managed care, EyeMed Vision Care, was appointed chair of its board of directors on November 14, at the 2025 Prevent Blindness annual board meeting here. MacDonald succeeds Jim McGrann, CEO of Advancing Eyecare, who was named an emeritus member of the board. At…
Scotlens, a leading custom contact lens manufacturer, has unveiled its refreshed brand identity at the Hospital and Specialty Optometrists Conference (8–9 November 2025). The rebrand follows its acquisition by Contact Lens Precision Laboratories (CLPL) six months ago and aligns Scotlens with CLPL and sister company Ultravision, which rebranded in 2024. “This integration strengthens our mission…
